Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China

被引:8
作者
Xiao, Xiaoqiang [1 ,3 ,4 ]
Xiang, Shunju [5 ,6 ]
Xu, Qingya [1 ,3 ,4 ]
Li, Jieying [1 ,3 ,4 ]
Xiao, Jun [1 ,3 ,4 ]
Si, Yang [2 ,4 ]
机构
[1] Sichuan Acad Med Sci, Sichuan Peoples Hosp, Dept Neuropsychol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Acad Med Sci, Sichuan Peoples Hosp, Dept Neurol, 32 W Sec 2, 1St Ring Rd, Chengdu 610072, Sichuan, Peoples R China
[3] Sichuan Prov Ctr Mental Hlth, Chengdu, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China
[5] West China Hosp, Dept Anesthesiol, Chengdu, Peoples R China
[6] Sichuan Univ, West China Sch Nursing, Chengdu, Peoples R China
关键词
Dementia; Alzheimer's disease; Vascular dementia; Risk; Comorbidity index; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; RISK; POLYPHARMACY; ASSOCIATION; MORTALITY; EPILEPSY; CANCER; EPIDEMIOLOGY;
D O I
10.1007/s40520-023-02349-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectiveTo investigate comorbidities among hospitalized patients with dementia.MethodData were extracted from the discharge records in our hospital. Comorbidities based on ICD-10 were selected from the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI). The distributions of these comorbidities were described in dementia inpatients and age- and sex-matched nondementia controls, as well as in inpatients with Alzheimer's disease and vascular dementia. A logistic regression model was applied to identify dementia-specific morbid conditions.ResultsA total of 3355 patients with dementia were included, with a majority of 1503 (44.8%) having Alzheimer's disease, 395 (11.8%) with vascular dementia, and 441 (13.1%) with mixed dementia. The mean number of comorbidities was 3.8 in dementia patients (vs. 2.9 in controls). The most prevalent comorbidities in inpatients with dementia compared with those without dementia were cerebral vascular disease (73.0% vs. 35.9%), hypertension (62.8% vs. 56.2%), and peripheral vascular disease (53.7% vs. 31.2%). Comorbidities associated with dementia included epilepsy (OR 4.8, 95% CI 3.5-6.8), cerebral vascular disease (OR 4.1, 95% CI 3.7-4.5), depression (OR 4.0, 95% CI 3.2-5.0), uncomplicated diabetes (OR 1.5, 95% CI 1.4-1.7), peripheral vascular disease (OR 1.8, 95% CI 1.6-2.0), rheumatoid arthritis collagen vascular disease (OR 1.7, 95% CI 1.3-2.3), and anemia (OR 1.2, 95% CI 1.04-1.3). Some comorbidities suggested a protective effect against dementia. They were hypertension (OR 0.8, 95% CI 0.7-0.9), COPD (OR 0.6, 95% CI 0.5-0.6), and solid tumor without metastasis (OR 0.4, 95% CI 0.3-0.4). Vascular dementia has more cardiovascular and cerebrovascular comorbidities than Alzheimer's disease.ConclusionPatients with dementia coexisted with more comorbidities than those without dementia. Comorbidities (esp. cardio-cerebral vascular risks) in patients with vascular dementia were more than those in patients with AD. Specifically, vascular and circulatory diseases, epilepsy, diabetes and depression increased the risk of dementia.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 63 条
  • [51] Predicting in-hospital mortality for dementia patients after hip fracture surgery - A comparison between the Charlson Comorbidity Index (CCI) and the Elixhauser Comorbidity Index
    Tang, Pei-Ling
    Lin, Huey-Shyan
    Hsu, Chien-Jen
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2021, 26 (03) : 396 - 402
  • [52] Dementia increases mortality beyond effects of comorbid conditions: A national registry-based cohort study
    Taudorf, Laerke
    Norgaard, Ane
    Brodaty, Henry
    Laursen, Thomas Munk
    Waldemar, Gunhild
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (07) : 2174 - 2184
  • [53] Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study
    Thapaliya, Kailash
    Harris, Melissa L.
    Byles, Julie E.
    [J]. EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2021, 3
  • [54] A New Elixhauser-based Comorbidity Summary Measure to Predict In-Hospital Mortality
    Thompson, Nicolas R.
    Fan, Youran
    Dalton, Jarrod E.
    Jehi, Lara
    Rosenbaum, Benjamin P.
    Vadera, Sumeet
    Griffith, Sandra D.
    [J]. MEDICAL CARE, 2015, 53 (04) : 374 - 379
  • [55] van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5
  • [56] The impact of charlson comorbidity index on mortality from SARS-CoV-2 virus infection and A novel COVID-19 mortality index: CoLACD
    Varol, Yelda
    Hakoglu, Burcin
    Cirak, Ali Kadri
    Polat, Gulru
    Komurcuoglu, Berna
    Akkol, Berrin
    Atasoy, Cagri
    Bayramic, Eda
    Balci, Gunseli
    Ataman, Sena
    Ermin, Sinem
    Yalniz, Enver
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [57] Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study
    Vetrano, Davide L.
    Tosato, Matteo
    Colloca, Giuseppe
    Topinkova, Eva
    Fialova, Daniela
    Gindin, Jacob
    van der Roest, Henriette G.
    Landi, Francesco
    Liperoti, Rosa
    Bernabei, Roberto
    Onder, Graziano
    [J]. ALZHEIMERS & DEMENTIA, 2013, 9 (05) : 587 - 593
  • [58] Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
    Winchester, Laura M.
    Powell, John
    Lovestone, Simon
    Nevado-Holgado, Alejo J.
    [J]. GENOME MEDICINE, 2018, 10
  • [59] Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI
    Wolters, Frank J.
    Zonneveld, Hazel I.
    Licher, Silvan
    Cremers, Lotte G. M.
    Ikram, M. Kamran
    Koudstaal, Peter J.
    Vernooij, Meike W.
    Ikram, M. Arfan
    van Buchem, Mark A.
    Biessels, Geert Jan
    la Rocca, Hans-Peter Brunner
    De Craen, Anton J.
    van der Flier, Wiesje M.
    Kappelle, L. Jaap
    Mooijaart, Simon P.
    Niessen, Wiro
    van Oostenbrugge, Robert
    de Roos, Albert
    van Rossum, Albert C.
    Daemen, Mat J.
    [J]. NEUROLOGY, 2019, 93 (09) : E917 - E926
  • [60] Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging
    Xia, Ying
    Yassi, Nawaf
    Raniga, Parnesh
    Bourgeat, Pierrick
    Desmond, Patricia
    Doecke, James
    Ames, David
    Laws, Simon M.
    Fowler, Christopher
    Rainey-Smith, Stephanie R.
    Martins, Ralph
    Maruff, Paul
    Villemagne, Victor L.
    Masters, Colin L.
    Rowe, Christopher C.
    Fripp, Jurgen
    Salvado, Olivier
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 321 - 334